发明名称 |
Diabetic control by combined insulin forms |
摘要 |
Peripherally administered insulin fails to provide liver hormone function. Hepatocyte directed vesicles with encapsulated insulin will restore liver function, but there is no non-targeted insulin to bypass the liver for peripheral use, as in natural, healthy body function. Whenever a prescribed dosage of insulin is divided between free and encapsulated hepatocyte targeted forms, a very small fraction of the dose in encapsulated form is sufficient to elicit full liver function, and non-targeted insulin supplies the needs of the body muscle and tissue.
|
申请公布号 |
US4863896(A) |
申请公布日期 |
1989.09.05 |
申请号 |
US19880143180 |
申请日期 |
1988.01.13 |
申请人 |
TECHNOLOGY UNLIMITED, INC. |
发明人 |
GEHO, W. BLAIR;LAU, JOHN R. |
分类号 |
A61K8/14;A61K9/127;A61K38/28;A61K47/48;A61Q11/00 |
主分类号 |
A61K8/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|